Should Pseudoephedrine (PSE) Be Moved from Behind the Counter to Prescription-Only? An Analysis of PSE as an OTC Medication and a Precursor for Methamphetamine Production by Dillon, Jerry
University of Kentucky 
UKnowledge 
MPA/MPP Capstone Projects Martin School of Public Policy and Administration 
2011 
Should Pseudoephedrine (PSE) Be Moved from Behind the 
Counter to Prescription-Only? An Analysis of PSE as an OTC 
Medication and a Precursor for Methamphetamine Production 
Jerry Dillon 
University of Kentucky 
Follow this and additional works at: https://uknowledge.uky.edu/mpampp_etds 
 Part of the Health Policy Commons, and the Pharmacy Administration, Policy and Regulation 
Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Dillon, Jerry, "Should Pseudoephedrine (PSE) Be Moved from Behind the Counter to Prescription-Only? An 
Analysis of PSE as an OTC Medication and a Precursor for Methamphetamine Production" (2011). MPA/
MPP Capstone Projects. 96. 
https://uknowledge.uky.edu/mpampp_etds/96 
This Graduate Capstone Project is brought to you for free and open access by the Martin School of Public Policy 
and Administration at UKnowledge. It has been accepted for inclusion in MPA/MPP Capstone Projects by an 
authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
Dillon 1 
 
 
 
 
Should Pseudoephedrine (PSE) be moved from Behind the Counter to 
Prescription-Only? 
An analysis of PSE as an OTC medication and a precursor for methamphetamine production 
 
 
 
 
Jerry Dillon, MPA/Pharm D Candidate, 2011 
 
 
 
 
 
Dillon 2 
 
Executive Summary 
 Kentucky State Senator Tom Jensen recently sponsored Senate Bill 45, which would 
change pseudoephedrine (PSE) from an over-the-counter to a schedule V prescription-only 
drug.48  The bill failed, but the debate continues as to whether Kentucky should make PSE, a 
precursor required to manufacture illicit methamphetamine, a controlled drug that is available by 
prescription only.   
 Methamphetamine abuse has been increasing in Kentucky as well as in the rest of the 
country, despite efforts to control the sale of PSE through federal and state legislation.  The 
Combat Methamphetamine Epidemic Act (CMEA) of 2006 and Kentucky’s initiative to 
electronically monitor the sales of PSE have both resulted in a decrease in the number of meth 
labs in Kentucky.  However, those decreases were followed shortly by sharp rebounds, with the 
number of labs in 2010 surpassing 1,000.18   
 If previous measures have been unsuccessful, can we expect prescription-only legislation 
to have the desired effect of reducing methamphetamine abuse in Kentucky?  This approach has 
seemed to have worked for Oregon, and has recently been adopted by Mississippi.21  The 
primary purpose of this paper is to analyze efforts made by Kentucky and other states to reduce 
methamphetamine abuse.  In order to determine if those efforts were successful, research has 
been conducted concerning the number of methamphetamine labs and hospital admissions 
related to methamphetamine abuse in Kentucky as well as other states that have instituted laws 
more stringent than federal regulations.  This analysis has been conducted over a range of years 
in order to compare the numbers of meth labs and hospital admissions both before and after 
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certain regulations were enacted in order to better determine the level of success of those 
measures.   
 In addition, this paper will address some other areas of concern related to the possibility 
of a prescription only PSE law in Kentucky such as; what are some of the methods 
methamphetamine abusers and ‘cookers’ have employed to bypass previous legislation, and how 
might they attempt to bypass future legislation?  If it can be determined that new legislation 
would fail to lead to a decrease in methamphetamine abuse, then perhaps alternative means of 
controlled methamphetamine use should be considered.  Finally, what is the practicality of 
making PSE prescription only?  PSE is not the only over-the-counter (OTC) medication 
available to treat symptoms related to nasal congestion, but is it the best alternative?  Are there 
other compelling reasons that might make a prescription-only law a benefit to the citizens of 
Kentucky?  How might a prescription-only law be a hindrance to Kentucky citizens who use PSE 
for its intended purpose?  These questions must be answered in addition to the primary research 
question in order to determine the advisability of a PSE prescription-only law in Kentucky.   
Introduction 
Kentuckians have a history of placing great emphasis on their strong moral beliefs as well 
as having a sense of entitlement for personal freedoms.  Sometimes these characteristics seem to 
clash, as they did during the ratification and later repeal of the 18th Amendment: prohibition of 
alcohol.32  Kentucky was the third state to ratify the prohibition of alcohol on January 14, 1918, 
with the expectation that prohibiting alcohol would lead to improved health, lower crime rates, 
and a better environment for young people.33  Fifteen years later, Kentucky voted to ratify the 
21st Amendment, which repealed the 18th Amendment, effectively ending prohibition.32  Whether 
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Kentuckians voted to repeal prohibition on grounds of personal freedoms, the realization that 
prohibition simply did not work, or that prohibition created more problems than it solved is a 
matter of debate.  The decision was likely fiscal as citizens became aware that the combination 
of loss of tax revenue from alcohol sales and the added expense of criminalizing the substance 
was bad for the economy.14   
Kentucky citizens were prepared to stand behind a law that would interfere with their 
personal freedoms in exchange for reduced crime and pursuing their high moral values.  In fact, 
many counties in Kentucky still prohibit the sale of alcohol to this day.15  Would Kentuckians 
stand behind a new law restricting access to a product in order to hopefully reduce crime?  Or 
will Kentuckians be leery of such a law as they are reminded of the failures of prohibition? 
Currently, Kentucky along with the rest of the nation faces a new drug problem: abuse of 
methamphetamine.  Methamphetamine is a highly regulated drug which can be obtained by 
prescription in the form of the brand name Desoxyn which is used to treat symptoms of ADHD.9  
An illegal form of methamphetamine can also be created using pseudoephedrine (PSE), a 
precursor that is available as an OTC nasal congestion remedy.  Currently, Kentucky legislators 
are debating whether to limit the sale of PSE to prescription only.  Few Kentuckians would 
advocate for the right to purchase OTC methamphetamine, but what about a precursor that is 
generally harmless if used appropriately and in the manner intended?  Would Kentuckians 
sacrifice their ability to purchase OTC PSE in exchange for reducing the abuse of 
methamphetamine, particularly if there is a lack of OTC medications as effective as PSE at 
reducing nasal congestion symptoms?  Would restricting PSE even lead to a reduction in abuse, 
or would abusers and producers figure out a way around the system?  Answering these questions 
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would help determine whether the sale of PSE should be prescription-only in the state of 
Kentucky.   
History 
The stimulant methamphetamine was first synthesized in Japan in 1893.2  
Methamphetamine was subsequently used by American, German, English, and Japanese soldiers 
during World War II for its ability to enhance energy levels and alertness for prolonged periods 
of time.3  Methamphetamine production and abuse made its way from Japan to Hawaii and 
California following World War II, and has since become widely produced and abused 
throughout the United States.1  Over the last 20 years, methamphetamine use has become 
epidemic throughout the country, particularly in rural areas.1  The widespread abuse of 
methamphetamine, also known by its street names crystal meth, meth, speed, ice, crank, and poor 
man’s cocaine, is due in part to its relative ease of production and highly addictive properties.16 
Mechanism of Action 
 Methamphetamine is considered an anorexant, a stimulant, and a sympathomimetic.9  
Abusers of methamphetamine can expect a reduced appetitive along with stimulation of the 
“flight or fight” response.  This includes increased heart rate due to direct actions on the heart 
muscle, increased blood pressure due to constriction of blood vessels, and the release of other 
stimulating hormones that can lead to aggression, anxiety, hostility, and paranoia.1 
The release of these hormones is part of why methamphetamine is such a highly addictive 
substance.1    Methamphetamine ingestion, inhalation, or injection causes a release of excitatory 
neurotransmitters such as norepinephine, serotonin, and dopamine.5   Norepinephrine is 
responsible for most of the stimulant effects of methamphetamine, while dopamine and serotonin 
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trigger reward pathways and enhance mood.  Following methamphetamine use, whether the user 
is a chronic addict or a first time user, the person will typically experience withdrawal.  The 
withdrawal can last for days for the occasional user, for chronic users it can last for weeks or 
even months.6  Withdrawal symptoms include fatigue, depression, anxiety, agitation, and suicidal 
ideation.6  For many users of methamphetamine, the only way to eliminate or prevent the 
symptoms of withdrawal is to continue using.   
Costs of Abuse 
Not only is methamphetamine highly addictive and easy to make, it is costing the United 
States approximately 20 billion dollars annually due to health care expenses, environmental 
damage, law enforcement costs, and lost production.7  This is a 2005 estimate; the current cost of 
fighting and treating methamphetamine abuse may be higher.  Law enforcement costs include 
not only arresting meth producers, but also clean-up of homes that have meth labs. The total cost 
to law enforcement just to investigate and clean-up meth labs in Kentucky in 2009 was nearly 
1.8 million dollars.19   Decontamination is essential before any person can re-enter the home in 
which a meth lab was in operation.  Then there are numerous other costs that are more difficult 
to pin down such as the cost to a family with a methamphetamine addict: poor school 
performance of children of addicts, and lost wages for family members who have to miss work in 
order to support their addicted family members.   
Specific Health Consequences 
 The combination of lack of sleep, lack of nutrient intake, and increased blood pressure 
can lead to heart disease, stroke, and myriad of other health complications.  One common health 
issue is the development of “meth-mouth” which can occur after only a few months of chronic 
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use.37  According to the American Dental Association, meth-mouth is likely induced by a 
number of factors directly resulting from methamphetamine use including dry mouth, and teeth 
grinding.38  Indirect effects of methamphetamine abuse that contribute to meth mouth are poor 
dental hygiene that is common to drug addicts in general, and the consumption of sugared soft 
drinks common to those who abuse stimulants.38   
 Another major health issue that has been shown in the media and used as a deterrent 
against methamphetamine abuse is the induction of the aging process, particularly concerning the 
face.  Meth mouth is part of this; the aging process also includes facial sores resulting from 
picking and scratching when a user thinks they have bugs on their face.39  The aging process is 
further enhanced because methamphetamine reduces blood flow to extremities, including the 
face, which, along with a poor diet, results in an inadequate nutrient supply; inevitably speeding 
up the aging process.39 
 In addition to the adverse effects on the heart and the visual side effects of the enhanced 
aging process, methamphetamine addiction has deleterious effects on the brain.  
Methamphetamine abuse results in the release of oxidative enzymes which attack and destroy 
neurons in the brain.36  Damage to neurons can be lifelong, persisting well after a person 
discontinues use of this drug.    
Making Methamphetamine 
The process of ‘cooking’ methamphetamine can be just as dangerous as injecting, 
smoking, or snorting.  The danger imposed by making the drug is due to the fact that several 
highly toxic compounds are required to make methamphetamine.  Methamphetamine production 
is relatively cheap and easy, requiring only the OTC product PSE or ephedrine to act as a 
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precursor, and some noxious chemicals such as red phosphorous and iodine to reduce (‘reducing’ 
is a chemical process whereby one chemical structure is changed into a similar but distinctly 
different structure) the precursor to methamphetamine.  The chemicals needed to make 
methamphetamine, which may include lithium from batteries, are highly toxic and explosive.  In 
fact, many meth labs are discovered following a fire or explosion resulting from the highly 
reactive process of “cooking” the drug.1  In addition to the explosive nature of meth labs, it has 
been estimated that for every pound of methamphetamine produced, six pounds of toxic waste 
are also created.1  That toxic waste is often dumped in rivers or drainage ditches.1 
Meth Lab Fires and Chemical Inhalation 
 Many methamphetamine “cookers” as well as innocent victims have been injured or lost 
their lives as a result of a methamphetamine explosion or fire.  Recently, three children lost their 
lives in a meth lab fire in Georgia resulting in a large amount of national press.40  Although this 
is just one example of the dangers of methamphetamine labs, there are numerous indications that 
treating meth burn victims is becoming an increasingly frequent event at burn units across the 
country.41  The implications of this finding are two-fold: first that innocent people (often 
children) are victims because they are unfortunate enough to live with someone who cooks meth; 
and that victims of methamphetamine abuse, whether they are innocent bystanders, cookers, or 
users, can be costly to treat. 
 Children are the most likely to be affected by fires and toxic inhalation of chemicals 
because they remain indoors while the noxious chemicals are being ‘cooked.’42  Inhalation of the 
toxic chemicals has led to health issues for children including increased levels of agitation and 
even induction of seizures.42  In local news, a 20 month old living in Wayne County died after 
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accidentally ingesting drain cleaner that was left in a cup on the table.  The drain cleaner was an 
ingredient the child’s relatives were allegedly using as an ingredient to ‘cook’ 
methamphetamine.43 
Federal Efforts to Control the Production/Abuse of Meth 
As early as the 1980’s, methamphetamine abuse had become a nationwide problem.27  
The abuse became more prevalent in the 90’s and early part of this century, prompting Congress 
to enact the Combat Methamphetamine Epidemic Act (CMEA) in 2005.8  This law introduced a 
federal limitation on the purchase of PSE with the hope that limiting the sale of PSE would lead 
to a decrease in the production and abuse of methamphetamine.  The CMEA requires the sale of 
PSE be limited to 3.6 grams per person per 24 hour period, and also limits each individual to 
purchases of 9 grams of PSE in a 30 day period.  In order to ensure that a person does not exceed 
the limit, each individual who buys PSE must produce a valid state ID and the transaction must 
be recorded either in a log book or electronically.8  The CMEA, which was introduced in 2005 
and became fully implemented on September 30, 2006, seems to have had an initial positive 
impact on reducing the number of meth labs throughout the U.S.8  
National Trends in the Number of Meth Labs 
The El Paso Intelligence Center (EPIC) collects data on the number of methamphetamine 
laboratory incidents throughout the US.  EPIC uses data collected from the Clandestine 
Laboratory Seizure System (CLSS) which is a system for states to document the number of labs 
and materials for making methamphetamine that are seized each year.  These data can be used to 
analyze the success of federal legislation, or legislation from individual states.  Tracking these 
seizures from year to year, and comparing the number of labs before and after certain legislations 
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have been enacted, will give in impression of whether that legislation was effective.  
Additionally, tracking the number of methamphetamine labs several years after legislation was 
enacted would allow one to see if that legislation remained effective over time. 
According to data from CLSS, the CMEA appeared successful in deterring 
methamphetamine production in the United States as the number of methamphetamine 
laboratory incidents decreased from approximately 18,500 in 2004 to a low of 6,200 in 2007.28  
Unfortunately, this trend seems to be reversing itself as the following years reported a steady rise 
in the number of labs up to just over 10,000 in 2010.28  If the federal law has only been able to 
temporarily stymie efforts to produce illicit methamphetamine, have individual states had more 
luck? 
Number of Methamphetamine Lab Incidents by State 
Given the costs to family members, the community, and society at large, many states 
have enacted various laws that limit the sale of PSE.  For example, Oregon, Mississippi, and 
several counties in Missouri require that consumers obtain a prescription from their physician in 
order to purchase PSE.20,21  Mississippi and Missouri have only recently enacted their laws 
(2010); the data has not yet been collected and analyzed to determine if their prescription-only 
policies have been successful.  Oregon has required prescriptions for PSE for several years 
beginning on April 5, 2006.20  The number of labs in Oregon subsequently dropped from 191 in 
2005 to a low of 9 in 2010.28   
Other states have implemented regulations to reduce the abuse of methamphetamine, but 
have had not shown success in reducing the number of lab incidents.  This might be due to the 
lack of monitoring to ensure that each individual does not exceed the federal limit of PSE 
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purchases.  Most states still use log books to record transactions, which only limits the amount of 
PSE an individual can buy at a single pharmacy; it does not prevent that person from getting PSE 
from several different pharmacies.  Some states, such as Kentucky, Arkansas, and Oklahoma 
electronically monitor PSE sales in order to better ensure that consumers are not exceeding the 
federally allowable limit of PSE by making purchases at several different pharmacies.17,22,23  
Despite the electronic monitoring of PSE, these states have not demonstrated a reduction in their 
number of meth labs discovered by law enforcement.  The number of statewide meth labs in 
Kentucky rose from 428 in 2008 (the first full year following the implementation of the 
electronic monitoring) to 1060 labs in 2010.18  Arkansas and Oklahoma have experienced similar 
results as Kentucky; a drop in methamphetamine labs following implementation of CMEA, 
followed by a subsequent increase in labs despite electronic monitoring.  The number of meth lab 
incidents and important legislations dates for the following states; Arkansas, Kentucky, 
Oklahoma, Oregon, and South Carolina; have been highlighted in figures 1 through 7.  Data from 
South Carolina has been used to act as a control, as South Carolina does not impose any limits or 
regulations above and beyond the CMEA.   
Important Dates and Legislation from 2004 
In 2004, two states initiated laws attempting to discourage the use of PSE for the purpose 
of acting as a precursor to methamphetamine, thus reducing the amount of methamphetamine 
abuse and subsequent costs to health care, law enforcement, and the environment.  Oklahoma’s 
HB 2176, which required that PSE-containing products could only be purchased at a pharmacy 
after showing valid ID and the pharmacist logged the entry, became active law on June 6, 2004.29  
Similarly, Oregon’s Board of Pharmacy issued a regulation with nearly the exact same 
restrictions as Oklahoma, although there was not a requirement to keep a log of the sales.30  A 
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literature search did not produce data on the number of methamphetamine labs for these states 
from 2003, so no before and after comparison was able to be made following these regulations. 
Important Dates and Legislation from 2005 
In 2005, Arkansas’ Board of Pharmacy adopted Act 256 effective March of that year 
which changed the status of PSE to a schedule V drug* which effectively limited the number of 
PSE medications that could be sold to an individual at one time.31  Consequently, the number of 
labs in Arkansas was reduced from 828 in 2004 to 490 in 2005.  In addition, Oregon’s Board of 
Pharmacy strengthened its restriction from the previous year to include a provision requiring that 
pharmacies maintain a log of all PSE sales beginning May 14, 2005.20 
2005 also marked the first full year that Oklahoma’s and Oregon’s original restrictions 
were in place.  Consequently, both states saw a marked decline in the number of 
methamphetamine laboratory incidents from 2004 to 2005; from 467 to 191 for Oregon and from 
699 to 240 for Oklahoma.28  The three states that had not enacted legislation between 2004 and 
2005 (Kentucky, Mississippi, and South Carolina) also showed a decline in their number of 
methamphetamine labs during this period, although the decline is much less impressive (see 
Figure 1, page 35). 
Important Dates and Legislation from 2006 
2006 marked the year that the CMEA went into effect (September).8  The number of labs 
decreased nationally from over 13,000 in 2005 to less than 8,500 in 2006.  Oregon’s 
 
*  A scheduled drug is one that has been determined by the FDA and or DEA to have the potential for abuse.49  Schedule I drugs are considered to 
have very high abuse potential and are not available by prescription in the U.S.  Schedule II – V are available by prescription and are subject to 
stricter prescribing controls compared to non-scheduled drugs.  The categories of abuse potential rank from schedule I drugs having the greatest 
potential for abuse, to schedule V having the least.49  
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House Bill 2485, which restricts PSE to prescription-only status, went into effect on July 1 of 
that year.20  The number of labs in Oregon decreased considerably from 191 in 2005 to 51 in 
2006 (see Figure 1).  In addition to the reduction in the number of reported meth labs, the state of 
Oregon experienced an overall decrease in reported number of crimes in 2006.  The crime rate 
for Oregon decreased by 4.9% 2006, versus relatively modest decreases in crime of 0.1% in 2005 
and 0.6% in 2004.57  The significance of this is unknown, as a correlation between the drop in 
number of discovered meth labs and a drop in the number of reported crimes cannot be made at 
this time.  
 Oklahoma and Arkansas also noticed decreases in the number of labs, but this followed a 
national trend and it is unclear whether this decrease was due to their individual regulations or 
the new federal regulation. 
Important Dates and Legislation from 2007 
2007 was the first year that any state adopted an electronic monitoring system to monitor 
PSE sales.  The intention of electronic monitoring is to better enable those states to limit 
individual PSE sales to only those allowed by the federal or state law.  Electronic monitoring 
allows ‘real time’ monitoring of PSE sales.  This prevents an individual from exceeding the state 
and federal imposed daily and monthly limits at the point of sale.  Kentucky began using an 
electronic monitoring system in accordance with Senate Bill 88 which became effective on April 
5, 2007.17  Oklahoma began electronic monitoring in August of the same year.23  Laboratory 
declines were seen in both states, as well as declines in Oregon, Arkansas, Mississippi (which 
did not have additional controls on PSE prior to 2010) and South Carolina (the control state).  
Once again, the state of Oregon reported a decrease in overall crime; a 3.1% drop from the year 
before.57  
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Important Dates and Legislation from 2008 
Arkansas implemented an electronic monitoring system on May 15, 2008 in its effort to 
further reduce methamphetamine abuse.22  Despite this, Arkansas experienced a modest rise in 
the number of labs, a trend that was seen throughout the country as well as in Kentucky, 
Oklahoma, Mississippi, and South Carolina.  The only state mentioned in this report that 
experienced a decline in the number of labs (albeit a small one) was Oregon (Figure 1), which is 
also the only state in the country that had a prescription-only law at this time.  In addition, 
Oregon again reported a decrease in crime, down 3.9% when compared to statistics from 2007.57 
Important Dates and Legislation from 2009 
In 2009, the trend is similar to the year before, with the same five states of Arkansas, 
Kentucky, Oklahoma, Mississippi and South Carolina experiencing an increase in the number of 
methamphetamine labs.  This occurred despite the electronic monitoring in Kentucky, Oklahoma 
and Arkansas.  In fact, the number of methamphetamine labs nationally rose from about 7,500 in 
2008 to over 10,000 in 2009.28  Oregon, however, experienced a continuing decline in the 
number of labs without a subsequent increase in the number of labs in neighboring states.28   
Important Dates and Legislation from 2010 
 Mississippi’s prescription-only law became effective July 1, 2010.21  It is difficult to say 
whether this has had an impact on the number of meth labs in Mississippi to date, because the 
number of reported labs in 2010 is nearly identical to those reported in 2009.  However, the 
number of labs in Mississippi had increased from 159 in 2007 to 691 in 2010; this number might 
have continued to increase if not for the new prescription regulation.  The number of labs in 
Kentucky rose by over one-third compared to the previous year (see Figure 1, page 35).   
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 The information contained in Figure 1 offers some insight as to whether other states, as 
well as Kentucky, have been successful in deterring the production of methamphetamine.  It 
would appear, according to the data from EPIC concerning the number of meth labs, that 
legislation typically has an immediate effect followed by a rebound after several years.  The only 
state that does not follow this pattern is Oregon, a state which only allows the sale of PSE by 
prescription.  Mississippi also only allows PSE to be sold with a prescription, but unfortunately 
there is a lack of data for comparing the number of meth labs before and after the law because 
the law was put in effect in 2010.  Another means of determining whether the incidence of 
methamphetamine abuse is on the rise or decline would be to examine hospital data.  This may 
be a better indicator of the actual level of abuse because people might be better at hiding meth 
labs, are producing smaller levels of methamphetamine; thus better evading detection, or could 
be getting their methamphetamine from another state.    
Admissions Data Related to Methamphetamine Abuse 
 Hospital admissions related to amphetamine abuse were identified using data from the 
Healthcare Cost Utilization Project (HCUP).  HCUP is a family of databases sponsored by the 
Agency for Healthcare Research and Quality (AHRQ).50  In order to capture all of the relevant 
data specific to amphetamine abuse, a literature search was conducted to see if this type of 
research had been conducted previously.  A study by Cunningham and Liu compared hospital 
admissions related to methamphetamine abuse over time.44  In order to simplify their search, they 
used a set of standardized codes; the International Classification of Diseases 9th revision (ICD9).  
ICD codes are used to classify any number of health conditions including diseases, injuries, 
symptoms, behavioral disorders, poisonings, etc…54  The ICD codes are periodically updated by 
the World Health Organization (WHO) in order to facilitate the tracking of statistics related to 
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morbidity and mortality.54  ICD codes are also used by insurance companies for the purposes of 
billing information.  Cunningham and Liu used a set of ICD9 codes related to amphetamine 
abuse, as there is not currently an ICD9 code distinguishing other amphetamines from 
methamphetamine.  Methamphetamine is a type of amphetamine, but amphetamine drugs are 
used in a number of ADHD treatments as well as several weight loss drugs; thus possibly 
skewing the results.  However, Cunningham and Liu were able to determine that most hospital 
admissions related to amphetamine abuse were actually the result of a methamphetamine 
overdose.44  Therefore, this study will make a similar assumption; the ICD9 codes specific to 
amphetamines will act as a good indicator of the actual number of hospital admissions related to 
methamphetamine abuse. 
 Similar to the study by Cunningham and Liu, the research for this paper used the ICD9 
codes 304.4 (amphetamine and other psychostimulant dependence), 305.7 (amphetamine or 
related acting sympathomimetic abuse), 969.7 (pyschostimulant poisoning), and E854.2 
(accidental psychostimulant poisoning).  
The data were retrieved from the HCUP database for Kentucky, South Carolina, and 
Oregon during the years 2001, 2006, and 2008.  South Carolina was chosen to act as a ‘control’ 
as the laws of this state concerning PSE sales are no more stringent than the federal 
requirements.  Oregon was chosen because it has a state law requiring that any person must have 
a prescription in order to purchase a product containing PSE.20  These years were chosen both for 
availability of data as well as providing data prior to and after state and federal legislation 
limiting the sale of pseudoephedrine products.  The federal government limited the sale of PSE 
to 3.6 grams per 24 hours per person and 9 grams per 30 days per person beginning in 2006.8  
Oregon began limiting PSE sales to prescription-only beginning in July, 2006 (the 2006 data 
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should partially reflect the implementation of that law) and Kentucky began keeping electronic 
records of transactions in April 2007.  Therefore, the 2008 data would reflect the first full year 
following the implementation of the electronic monitoring.  Unfortunately, the data for 2010 
were not able to be retrieved.  This would have been helpful to determine whether or not there 
was a ‘rebound’ in methamphetamine abuse similar to the initial decline and eventual rise in the 
number of meth labs that were discovered by law enforcement immediately following the 
implementation of Senate Bill 88.  
Based on the data concerning the number of meth labs in the U.S., it might be expected 
that Oregon had the fewest number of hospital admissions due to methamphetamine abuse, while 
Kentucky had the most.  The results of the data, which can be found in Tables 1 through 3, 
suggest that the opposite is true.  Oregon’s total methamphetamine-related hospital admissions 
for the three years analyzed were 4 times greater than that of Kentucky and 6 times greater than 
South Carolina (Table 1).  This seems to suggest that the number of meth labs in a particular 
state, and the amount of methamphetamine abuse by the citizens of that state, are not necessarily 
correlated.  There are several possible explanations for this phenomenon. 
Table 1: Methamphetamine Related Hospital Admissions 
 2001 2006 2008 Total 
Kentucky 226 148 155 529 
Oregon 349 1020 730 2,099 
South Carolina 100 63 191 354 
Total 675 1,231 1,076 2,982 
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Heroin addicts who come to an emergency room for treatment of a non-fatal overdose 
have claimed their overdose was the result of taking a higher than normal amount of heroin, the 
heroin was stronger than usual, they used heroin after a period of sobriety, or some combination 
of these.55  Perhaps the meth users in Oregon use it less frequently due to the lack of availability; 
when they do use it is following a period of abstinence and they are more likely to overdose as a 
result.  This hypothesis is supported by a study of 137 patients who underwent a 28 day opiate 
detoxification program.  At the end of the program, participants were labeled as still tolerant 
(patients who failed to complete any portion of the detoxification), reduced tolerance (patients 
who left the program early), and lost tolerance (patients who successfully completed the 
program).56  In this study, those who successfully completed the program were more likely to die 
from an opiate overdose.56  Those who stayed beyond the initial 28 days of treatment were more 
likely to die of an opiate overdose than those who left the program immediately following the 
initial 28 day period.56  Kentuckians may have fewer trips to the hospital related to 
methamphetamine abuse because they are more likely to be chronic users with sustained levels 
of tolerance; thus protecting them from acute overdoses.  
 The median cost of treating a methamphetamine overdose in an inpatient setting has 
approximately doubled for each of the states analyzed between 2001 and 2008 (Table 2) despite 
a relatively stable median length of stay (Table 3).  Oregon has been successful in reducing the 
number of meth labs, which has possible led to a reduction in overall crime, as mentioned 
earlier.57  However, as the cost of treating meth abuse increases, and the number of hospital 
admissions in Oregon is much higher than that of Kentucky or South Carolina, has Oregon 
traded one expense for another?   
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Table 2: Median Hospital Charge per Admission Related to Methamphetamine Admissions 
 2001 2006 2008 
Kentucky 4,845 8,070 10,960 
Oregon 5,002 9,694 11,423 
South Carolina 6,275 10,904 12,702 
  
Table 3: Median Length of Stay per Methamphetamine Related Admission 
 2001 2006 2008 
Kentucky 3 3 4 
Oregon 2 3 3 
South Carolina 3 3 3 
  
Another possible explanation for the discrepancy in the number of hospital admissions 
versus the number of meth labs is that meth abusers in Oregon are able to continue using meth 
despite the laws that reduce the availability of the precursor PSE.  A review of the literature as 
well as an internet search has lead to several methods by which abusers of meth have been able 
to bypass the CMEA, electronic monitoring, and other state legislation.    
Meth from Mexico 
 Following the CMEA, the United States had a marked decrease in the number of 
methamphetamine laboratories.  Unfortunately, the decline in labs in this country was met with 
an immediate increase in the production and exportation of methamphetamine from Mexico.45  In 
fact, by one estimate from the DEA, 80% of methamphetamine used in the United States in 2007 
came from a Mexican-based drug cartel.45  It would appear that as long as PSE is available in 
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Mexico, the drug cartels there can continue to use PSE to create large batches of meth.  As long 
as meth is being produced in Mexico and transported across the border, there will unlikely be a 
shortage of supply here in Kentucky, regardless of the federal and state legislation designed to 
limit abuse. 
 According to the National Drug Intelligence Center (NDIC), Mexican officials 
implemented a ban on the importation of ephedrine and PSE in 2008.46  This led to zero 
commercial imports of PSE and ephedrine into Mexico beginning in 2008, which resulted in a 
subsequent decline in the production of methamphetamine by Mexican cartels during that same 
year.  Unfortunately, methamphetamine production was on the rise in the United States during 
that same year as ‘cookers’ discovered ways to obtain more PSE and how to make smaller 
batches of methamphetamine using the ‘shake and bake’ method (see page 24).  Similar to the 
production of methamphetamine here in the U.S., Mexican cartels quickly learned how to 
circumvent the ban on PSE imports and have begun diverting large supplies of PSE from other 
countries in South America.46  Despite a nationwide ban on the importation of PSE, Mexican 
drug cartels are once again producing large supplies of methamphetamine and exporting it to this 
country.   
Smurfing 
 Another method that has become popular throughout the country is ‘smurfing’ PSE.  This 
term was originally used to describe an individual breaking up a large transaction with a bank 
into several small ones in order to avoid raising any red flags with the IRS.46  Concerning PSE, 
smurfing is a means by which individuals purchase the daily limit they are allowed by the federal 
government at one pharmacy, and then going to another pharmacy and doing the same.46  This 
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method is not successful in states such as Kentucky that employ electronic monitoring.  
However, Kentucky is contiguous to seven states that do not use electronic monitoring; an 
individual from Kentucky could still purchase large quantities of PSE from sources in these other 
states.   
Stooges 
 A new method of procuring extra quantities of PSE, particularly in states that employ 
electronic monitoring systems, is to use ‘stooges.’  A stooge is someone who has been paid by 
another person to purchase their daily limit of PSE.47  Utilizing this method, a single person 
could obtain several times the daily or monthly limit in spite of electronic monitoring systems.  If 
electronic monitoring becomes more popular in other states, possibly through federal regulation, 
this method of obtaining PSE may become more popular.  However, cookers may have a 
difficult time finding an adequate number of stooges throughout the month, as a stooge would 
reach their 30-day limit of PSE rather quickly.     
Ephedrine 
 Even if there was a national legislation to make all PSE products available by 
prescription only, and if Mexico was unable to procure shipments of PSE from other countries in 
order to produce methamphetamine, a problem remains because ephedrine is still available over 
the internet.  A simple internet search using the word ephedrine on google.com will result in 
numerous websites that allow individuals to buy products containing ephedrine.  In the absence 
of PSE, it is reasonable to believe that methamphetamine could still be produced in large 
quantities until federal legislation restricts the ability to make purchases of the product over the 
internet.   
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 However, ‘cookers’ might be wary of making large internet purchases of PSE or 
ephedrine because there is no guarantee that the products purchased online are the same as the 
product advertised.  For example, a bottle of ephedrine purchased over the internet might contain 
nothing more than sugar pills.  PSE products purchased in the U.S. are regulated by the FDA and 
it is reasonable to assume that commercial PSE products purchased here will not be 
contaminated or adulterated (unlike ephedrine products that are not legally made or regulated in 
the U.S.); this is something that ‘cookers’ undoubtedly realize.     
The Shake and Bake 
Recently, a new method for making methamphetamine known as a “shake and bake” has 
become more prevalent.4  The shake and bake method of producing methamphetamine requires 
only an empty 2 liter bottle, a few PSE pills, and some common household chemicals.4  The 
amount of PSE required to make meth using this method is less than the 3.6 grams an individual 
is allowed to purchase in one 24 hour period under the current federal guidelines.8  This method 
is highly dangerous because the process of making meth is even more likely to lead to explosions 
as it requires the cooker to literally shake a bottle full of highly reactive ingredients.4  This new 
method requires that the ingredients be shaken appropriately and the cap be screwed on “just 
right” in order to ensure the product is made correctly without resulting in an explosion.   
This method has not been researched for this paper; a statement cannot be made as to the 
amount of methamphetamine that a single ‘shake and bake’ can produce, or whether that amount 
is sufficient to satisfy a typically abuser.  It is possible that this method yields only a limited 
supply of methamphetamine and cannot be expected to replace the more traditional labs for the 
chronic abuser.  If this method does produce sufficient quantities of meth each month with less 
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than 9 total grams of PSE, even a nationwide electronic monitoring program might not have an 
effect on reducing the abuse of this drug.    
Alternatives to PSE for the Treatment of Nasal Congestion 
Federal and state laws have been issued in order to reduce the availability of the key 
ingredient in the illegal manufacturing of methamphetamine, PSE.  These laws, particularly ones 
in which PSE is allowed to be sold by prescription only, reduce the availability of PSE to 
consumers.  This begs the question: are there viable alternatives to PSE readily available to 
patients who require nasal decongestants? 
Following national legislation to limit the sale of PSE, many producers of cold 
medications switched from PSE as the main ingredient to phenylephrine (PE).8  Sales of 
phenylephrine, the primary ingredient in cough and cold medicines such as Sudafed PE, are not 
regulated by the states or national government, as PE has no known abuse potential.  PE also 
works differently than PSE and has a much lower bioavailability of 38% (bioavailability is the 
measure of the amount of a drug that reaches systemic circulation following ingestion), 
compared to nearly 100% for PSE.12  As a result of having a different mechanism of action and a 
markedly lower bioavailability, PE has been shown to be inferior to PSE in treating symptoms of 
nasal congestion and has even failed to show superiority over placebo in treating nasal 
congestion in numerous clinical trials.10,11   
Despite the poor performance of PE in clinical trials, cold and allergy sufferers still have 
the option of using nasal sprays to alleviate their symptoms.  Xylometazoline, the active 
ingredient found in Afrin, is a nasal decongestant that has been proven to significantly reduce 
nasal congestion in people with the common cold.13  Additionally, there is no current method of 
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converting the decongestants found in nasal sprays into harmful or illicit drugs such as 
methamphetamine.  Unfortunately, nasal sprays can only be safely used for 3 to 5 days before 
they result in rebound congestion, leading to worse nasal suffering than the patient would have 
experienced if they had not used the spray at all.9  For this reason, nasal sprays are poor options 
for chronic allergy and sinus sufferers.  Given the lack of other oral decongestants available on 
the market, cold and allergy sufferers with chronic and persistent symptoms have few, if any, 
viable options other than PSE for the treatment of their symptoms. 
How Will Those Who Use PSE as it is Intended be Affected by a Prescription-Only Law? 
Many Kentuckians suffer from nasal congestion; whether in the form of seasonal 
allergies, chronic allergies, or bouts of the common cold.  According to one estimate, Louisville, 
KY has been ranked as the second worst city to live in for allergy sufferers.24  And according to 
PollenTec, a company that produces special window screens that allow airflow while preventing 
pollen and other allergens from entering the home, Lexington has the highest pollen count of any 
city in the country.25  For many Kentuckians, the ability to control symptoms might be greatly 
reduced if they are unable to purchase effective over the counter medications such as PSE.   
A prescription-only PSE regulation might result in only a minimal additional cost to 
Kentuckians, as most physicians would be willing to prescribe PSE without requiring an 
additional visit to the doctor’s office.47  If this is the case, then it is possible that making PSE a 
prescription-only product might cause an inconvenience without a marked increase in money 
spent on physician visits.  However, the median household income for Kentucky as of 2008 is 
$41,000 which is $11,000 less than the national average26.  In addition, 17% of Kentuckians have 
an income level below the poverty line, as compared with 13% nationally26.  Given this 
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information, can Kentuckians afford to treat their nasal congestion symptoms if PSE availability 
is restricted to those who have prescriptions from their physicians?     
Despite the additional costs to the individual for the treatment of their allergies, there is a 
potential for a great deal of savings to the state of Kentucky if the prevalence of 
methamphetamine abuse could be limited.  The estimated cost to the taxpayers of Kentucky in 
2009 related to methamphetamine abuse, including investigations, cleaning meth lab sites, 
arresting individuals, housing those who have been arrested, lab analysis, and man-hours, totaled 
more than 30 million dollars19.  There is also the concern that methamphetamine abuse is 
reducing our safety because of the amount of time police officers must devote to the crimes of 
manufacturing and abuse; approximately 35,000 man-hours were devoted to methamphetamine 
related crimes in 2010.19  These costs, in addition to the costs to hospitalize victims of 
methamphetamine abuse, which includes abusers as well as innocent victims who are injured in 
meth lab explosions, have prompted debates on whether to change PSE from a restricted OTC 
product to a prescription only medication. 
Finally, there is some evidence that PSE itself might warrant a prescription only status.  
PSE, even if used as intended, increases heart rate and blood pressure.9  Elevations in blood 
pressure can lead to numerous medical complications including damage to blood vessels that 
supply the heart, brain, kidneys, and eyes.52  Approximately 30% of U.S. adults have high blood 
pressure and should not take PSE without consulting their physician.9,51  Many of these people 
do not know they have high blood pressure; if they had to see their physician in order to obtain a 
prescription for PSE, the elevated blood pressure would possibly be discovered in the doctor’s 
office.  In addition to issues with high blood pressure, PSE is not approved for use in children 
under the age of 4.9  Despite this recommendation from the FDA and the American Pediatric 
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Society, children aged 2 and under consume the greatest amount of PSE containing products of 
any age range among children.53  Children in this age range are at the highest risk for toxicity 
from the PSE.53   
Limitations 
 The data concerning hospital admissions fails to capture emergency room visits that do 
not result in an admission to the hospital.  Ideally, the data would reflect all emergency room 
visits, whether or not they resulted in an admission.  The emergency department data is available 
for this research; however, the data was not able to be collected in the time allotted for 
completion of this paper.  The hospital admission data is also limited in that only three years 
were evaluated.  The data from 2001 is well before the implementation of the CMEA or other 
state specific regulations concerning PSE sales and distribution.  2008 is not the most recent year 
for which data are available (2010 data are available) but due to time constraints it was the most 
recent year available for analysis in this research.  A further analysis of this research should 
compare data over a greater number of years in order to detect trends, and should include the 
most recent year for which data is available.   
Another limitation is the data on meth labs discovered in Kentucky.  Are the numbers a 
true reflection of the number of labs, or has law enforcement become more efficient at 
discovering labs over the last few years?  In addition, with the advent of ‘mobile meth labs,’ it is 
difficult to determine whether the increase in meth labs is a reflection of the number of 
individuals abusing meth.  Mobile meth labs typically produce small amounts of 
methamphetamine compared with the more ‘traditional’ labs that can yield much greater 
amounts.  If the number of labs increase, but the yield from each lab decreases, how has the 
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overall production of meth changed?  A further limitation is the large amount of meth that comes 
from Mexico, estimated at 80% of the total meth used in the U.S.45  Given this statistic, is it even 
reasonable to assume that the number of labs in a given state is correlated to the amount of meth 
that is used in that state?  Finally, the numbers of meth labs from the Louisville Metro Police 
Department and from the DEA’s website reflect the total number of ‘incidents’ rather than the 
total number of labs.  For example, if a law enforcement agency responds to a home that has 5 
meth labs within the residence, the incident number is one.  Therefore the true number of meth 
labs is probably much higher than what is actually reported. 
 Another limitation is the use of data from a state that is not demographically similar to 
Kentucky.  Oregon cannot necessarily be directly compared to Kentucky as it is in a different 
region of the country and consists of a different makeup of citizens concerning education, 
income, population, and other pertinent statistics.26  Ideally, Mississippi would have been a better 
comparator, but as PSE has been prescription-only since 2010 in MS, versus 2006 in Oregon, the 
data for MS is lacking.              
Conclusion 
 Given the conflicting evidence concerning the number of meth labs, the number of 
hospital admissions, and the numerous ways in which an individual could produce and obtain 
illicit methamphetamine, it is difficult to predict the consequences of implementing a 
prescription-only PSE law in Kentucky.  Oregon appears to have had some success as it has a 
markedly reduced number of meth labs compared to before its prescription-only law, and the 
overall crime rates in Oregon have been reduced following the same law.  The greater number of 
hospital admissions in Oregon is discouraging and suggests a possible unintended consequence 
Dillon 28 
 
of reducing the immediate availability of methamphetamine to addicts; a decrease in tolerance 
followed by an overdose.  Time will tell whether Oregon has been successful in deterring 
methamphetamine consumption, but early indicators are promising.  If Kentucky can experience 
a similar decrease in the number of meth labs and a consequent decrease in overall crime, then 
changing PSE to prescription-only will have an overall positive impact on the citizens of 
Kentucky.       
Discussion 
 The efforts by Kentucky’s legislature to reduce the prevalence of methamphetamine 
abuse and production have so far been shown to be ineffective.  Following federal and state laws, 
Kentucky has seen a decrease in the number of methamphetamine labs, only to see those 
numbers steadily climb several years afterwards.  Only Oregon, which instituted a prescription-
only law in 2006, has seen a steady and lasting decrease in its number of methamphetamine labs.  
However, hospital admissions for methamphetamine abuse in Oregon have been much higher 
than similar hospital admissions in Kentucky.  Oregon may have outsourced its production of 
methamphetamine, but there is not clear evidence that use of meth has declined.   
 Further research is needed to determine all the pros and cons of a PSE prescription-only 
law.  One area of research that might be interesting to pursue is the adverse health consequences 
of the lay person using PSE for its intended purpose without having consulted a doctor 
beforehand.  For example, does OTC use of PSE lead to an increased incidence of hypertension?  
If so, what are the consequences of the increased hypertension?  Are there additional costs to 
healthcare?  Can PSE induced hypertension eventually lead to organ dysfunction such as kidney 
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damage?  If so, at what rate and at what cost to the healthcare system?  Answers to these 
questions can help decision makers weigh all the options when considering the status of PSE.   
 Changing the availability of PSE to prescription-only may help reduce production and 
consumption of meth in Kentucky in the short-term, but like previous laws may have little to no 
long-term impact.  When considering different ways to reduce drug abuse in Kentucky, it is 
important to consider changes that will have an immediate impact as well as policies and 
regulations that will prevent drug abuse in the future.  In order to accomplish this, it is necessary 
to consider the root causes of drug abuse.  Some questions to consider are: what makes a person 
use methamphetamine in the first place?  What characteristics, if any, do drug abusers have in 
common with each other?  Finally, what can we do to ensure that people are less likely to abuse 
drugs, regardless of how cheap and available they may be?  
 According to self-reporting statistics from 2009, college graduates abuse drugs at a lower 
rate than those who have graduated from high school or have dropped out (6.1% versus 8.8% 
versus 10.6%).34  The same survey showed that people who were employed full time were less 
likely to use illicit drugs versus those who were unemployed (8% versus 17%).  The Bureau of 
Labor Statistics has shown that in 2009, the level of income rose proportionately with education 
level, while the rate of unemployment was inversely proportional to education.35  Kentuckians 
have a lower than average level of education, lower than average salaries, and a higher than 
average propensity to abuse drugs.26  The best way to prevent methamphetamine abuse in 
Kentucky, or any form of drug abuse for that matter, would be to enhance our education system. 
 Investing in the education of the youth of Kentucky might prove to be a better deterrent 
to drug abuse than any law concerning the distribution of PSE.  A prudent policy might be to 
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limit PSE to prescription only and ask legislators to encourage federal legislation to do the same.  
If Kentuckians are unable to get PSE without a prescription from this or any other state, we 
might be able to better control the abuse of this drug and the myriad of problems that abuse leads 
to.  However, to have a lasting impact on drug abuse in general, Kentuckians need to be willing 
to invest more money in the education system, which would potentially lead to a decrease in all 
forms of drug abuse.     
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Figure 2: Electronic Monitoring States 
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Figure 3: Prescription-only states with control state (S. Carolina) 
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